Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

LABORATORY CORPORATION OF AMERICA HOLDINGS

NPI: 1679964613 · OVERLAND PARK, KS 66210 · Clinical Medical Laboratory · NPI assigned 02/12/2015

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official WILLIAMS, KIMBERLY controls 20+ related entities in our dataset. Read more

$6.64M
Total Medicaid Paid
215,900
Total Claims
200,429
Beneficiaries
40
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialWILLIAMS, KIMBERLY (VICE PRESIDENT)
NPI Enumeration Date02/12/2015

Related Entities

Other providers sharing the same authorized official: WILLIAMS, KIMBERLY

ProviderCityStateTotal Paid
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $1.44B
LABORATORY CORPORATION OF AMERICA HOLDINGS RARITAN NJ $717.47M
LABORATORY CORPORATION OF AMERICA HOLDINGS DUBLIN OH $617.02M
LABORATORY CORPORATION OF AMERICA HOLDINGS BIRMINGHAM AL $289.12M
LABORATORY CORPORATION OF AMERICA PHOENIX AZ $265.90M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $264.26M
LABORATORY CORPORATION OF AMERICA HOLDINGS CHARLESTON WV $220.04M
LABORATORY CORPORATION OF AMERICA SEATTLE WA $186.69M
LABORATORY CORPORATION OF AMERICA TAMPA FL $171.13M
LABORATORY CORPORATION OF AMERICA SAN DIEGO CA $147.14M
LABORATORY CORPORATION OF AMERICA HOUSTON TX $103.81M
LABORATORY CORPORATION OF AMERICA ENGLEWOOD CO $77.80M
LABORATORY CORPORATION OF AMERICA DALLAS TX $77.42M
LABORATORY CORPORATION OF AMERICA BURLINGTON NC $59.75M
MEDTOX LABORATORIES, INC SAINT PAUL MN $47.72M
LABORATORY CORPORATION OF AMERICA HOLDINGS BURLINGTON NC $15.65M
LABORATORY CORPORATION OF AMERICA SAN ANTONIO TX $11.67M
TRI-CITIES LABORATORY, LLC KENNEWICK WA $8.69M
LABORATORY CORPORATION OF AMERICA HOLDINGS MONROE LA $3.39M
LABORATORY CORPORATION OF AMERICA ITASCA IL $3.37M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,224 $187K
2019 21,526 $520K
2020 42,981 $1.25M
2021 96,856 $3.11M
2022 40,488 $1.23M
2023 3,651 $199K
2024 3,174 $142K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 37,573 32,218 $2.47M
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 36,615 34,902 $879K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 36,366 34,613 $872K
88305 Level IV - Surgical pathology, gross and microscopic examination 13,508 11,993 $699K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 21,570 20,326 $492K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 15,480 13,977 $302K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer 18,794 17,750 $287K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 11,814 11,343 $249K
88342 1,816 1,722 $84K
88307 631 593 $58K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies 1,901 1,841 $38K
88141 3,086 2,922 $37K
88304 1,521 1,449 $31K
87150 1,248 1,210 $26K
87086 Culture, bacterial; quantitative colony count, urine 3,634 3,519 $20K
88142 1,269 1,226 $14K
87625 748 736 $10K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 219 217 $10K
86803 1,050 1,021 $9K
87081 1,641 1,603 $7K
G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed 45 45 $5K
87340 720 690 $5K
86592 1,768 1,708 $5K
88341 68 64 $5K
86780 428 402 $4K
87088 508 499 $3K
87186 285 282 $2K
36415 Collection of venous blood by venipuncture 826 815 $1K
86696 94 92 $1K
84443 Thyroid stimulating hormone (TSH) 88 82 $1K
87077 187 186 $945.39
86695 82 80 $589.32
88302 38 36 $583.35
88312 12 12 $583.17
86850 72 70 $417.99
85025 Blood count; complete (CBC), automated, and automated differential WBC count 29 25 $151.28
86901 71 68 $148.24
86900 71 68 $148.24
80053 Comprehensive metabolic panel 12 12 $94.71
83036 Hemoglobin; glycosylated (A1C) 12 12 $78.34